Skip to main content
Clinical Trials/NCT01094730
NCT01094730CompletedNot Applicable

A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens

Johnson & Johnson Vision Care, Inc.9 sites in 1 country185 target enrollmentStarted: February 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
185
Locations
9
Primary Endpoint
Lens Front Surface Deposits at Day 7

Study Overview

Brief Summary

The purpose of this study is to compare lens surface characteristics and comfort between an experimental contact lens and a marketed contact lens.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 39 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •The subject must be at least 18 years of age and no more than 39 years of age.
  • •The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of daily wear (DW) for a minimum of 1 month prior to the study) and willing to wear the study lenses on a daily wear basis (defined as a minimum of 6 hours of wear per day at least five days of the week) for the duration of the study.
  • •The subject's optimal vertexed spherical equivalent distance correction must be between -1.00 and - 9.00D.
  • •Any cylinder power must be ≤ -0.75D.
  • •The subject must have visual acuity best correctable to 20/25+3 or better for each eye.
  • •The subject must read and sign the Statement of Informed Consent.
  • •The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion Criteria

  • •Ocular or systemic allergies or disease which might interfere with contact lens wear.
  • •Systemic disease or use of medication which might interfere with contact lens wear.
  • •Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.
  • •Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
  • •Any ocular infection.
  • •Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • •Pregnancy or lactation.
  • •Diabetes.
  • •Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
  • •Habitual contact lens type is toric, multifocal, or is worn as extended wear.

Arms & Interventions

galyfilcon A prototype/marketed galyfilcon A

Other

The galyfilcon A prototype lens worn daily for 12-16 days during the first period then the marketed galyfilcon A lens worn daily for 12-16 days during the second period.

Intervention: galyfilcon A prototype lens (Device)

galyfilcon A prototype/marketed galyfilcon A

Other

The galyfilcon A prototype lens worn daily for 12-16 days during the first period then the marketed galyfilcon A lens worn daily for 12-16 days during the second period.

Intervention: marketed galyfilcon A lens (Device)

marketed galyfilcon A/galyfilcon A prototype

Other

The marketed galyfilcon A lens worn daily for 12-16 days during the first period then the galyfilcon A prototype lens worn daily for 12-16 days during the second period; during each period.

Intervention: galyfilcon A prototype lens (Device)

marketed galyfilcon A/galyfilcon A prototype

Other

The marketed galyfilcon A lens worn daily for 12-16 days during the first period then the galyfilcon A prototype lens worn daily for 12-16 days during the second period; during each period.

Intervention: marketed galyfilcon A lens (Device)

Outcomes

Primary Outcomes

Lens Front Surface Deposits at Day 7

Time Frame: Evaluated at Day 7

Deposits on the front surface of each lens were examined by the investigator after 7 days of lens wear, and graded on a 5-point scale; 0 = no deposit, 1 = 1%-5% deposits, 2 = 6%-15% deposits, 3 = 16%-25% deposits, and 4 = 25% or more deposits. The grades were categorized into binary variable: grade 0 or 1 Vs. grade 2 or higher.

Lens Front Surface Deposits at Day 14

Time Frame: Evaluated at Day 14

Deposits on the front surface of each lens were examined by the investigator after 14 days of lens wear, and graded on a 5-point scale; 0 = 0% deposits, 1 = 1%-5% deposits, 2 = 6%-15% deposits, 3=16%-25% deposits, and 4= 25% or more deposits. The grades were categorized into binary variable: grade 0 or 1 vs. grade 2 or higher.

Secondary Outcomes

  • Subject Reported Overall Lens Comfort at Day 7(Evaluated at Day 7)
  • Subject Reported Overall Lens Comfort at Day 14(Evaluated at Day 14)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (9)

Loading locations...

Similar Trials

Pilot Evaluation of a New Galyfilcon A... | Clinical Trial